Package 62856-389-01

Brand: halaven

Generic: eribulin mesylate
NDC Package

Package Facts

Identity

Package NDC 62856-389-01
Digits Only 6285638901
Product NDC 62856-389
Product ID 62856-389_2c75a415-0b1e-4c36-8301-c50ac155d980
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (62856-389-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2010-11-15
Brand halaven
Generic eribulin mesylate
Sample Package No

Linked Drug Pages (1)

Halaven ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2c75a415-0b1e-4c36-8301-c50ac155d980", "openfda": {"unii": ["AV9U0660CW"], "rxcui": ["1045456", "1045460"], "spl_set_id": ["31ce4750-ded5-4a0b-95e9-f229fa6bc822"], "manufacturer_name": ["Eisai Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (62856-389-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "62856-389-01", "marketing_start_date": "20101115"}], "brand_name": "Halaven", "product_id": "62856-389_2c75a415-0b1e-4c36-8301-c50ac155d980", "dosage_form": "INJECTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "62856-389", "generic_name": "eribulin mesylate", "labeler_name": "Eisai Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Halaven", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "NDA201532", "marketing_category": "NDA", "marketing_start_date": "20101115", "listing_expiration_date": "20261231"}